Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 May 8;12(5):711-712.
doi: 10.2215/CJN.03490317. Epub 2017 May 4.

Understanding Histolopathologic Characteristics to Predict Renal Outcomes in Lupus Nephritis

Vladimir Tesar  1 , Zdenka Hruskova
Affiliations
Editorial

Understanding Histolopathologic Characteristics to Predict Renal Outcomes in Lupus Nephritis

Vladimir Tesar et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: histopathology; kidney; lupus nephritis.

PubMed Disclaimer

Comment on

References

    1. Rijnink, et al. : Clin J Am Soc Nephrol 12: 734–743, 2017 - PMC - PubMed
    1. Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G: Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77: 820–829, 2010 - PubMed
    1. Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, Liu G, Zhao MH: Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83: 715–723, 2013 - PubMed
    1. Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH: Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76: 307–317, 2009 - PubMed
    1. Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus: Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis Rheum 56: 924–937, 2007 - PubMed